Clinical Trial Update: Efficacy and Safety of Lenalidomide for Treatment of Autistic Spectrum Disorders [Phase 2]

View source ↗

Summary

Phase 2 trial assessing lenalidomide for autism spectrum disorders has completed with posted efficacy and safety results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder

Drugs mentioned

• Lenalidomide (Revlimid) (lenalidomide)

Snippet

Sponsor: Sutter Medical Foundation | Conditions: Autism | Phase 2 | Status: COMPLETED | Results posted: 2013-05-29